Clinical Endocannabinoid Deficiency Syndrome (CEDS) is an umbrella term for a group of illnesses, including fibromyalgia, migraine and irritable bowel syndrome. A growing number of respected scientists in the medical community think low levels of endocannabinoids are the root cause of these devastating conditions.
Medscape says there is scientific evidence suggesting endocannabinoids play a role in inflammation, insulin sensitivity, and fat and energy metabolism.
What Are Endocannabinoids?Human and animal bodies synthesize endocannabinoids naturally. In fact, the prefix “endo” means “made in the body.” Endocannabinoids are part of the larger endocannabinoid system that regulates appetite, pain sensation, mood, memory, and more.